Home/Filings/4/0001179110-13-002641
4//SEC Filing

Neumayer Matthew Paul 4

Accession 0001179110-13-002641

CIK 0001360886other

Filed

Feb 12, 7:00 PM ET

Accepted

Feb 13, 5:36 PM ET

Size

5.4 KB

Accession

0001179110-13-002641

Insider Transaction Report

Form 4
Period: 2013-02-12
Neumayer Matthew Paul
Principal Accounting Officer
Transactions
  • Award

    Incentive Stock Option (right to buy)

    2013-02-12$7.73/sh+3,500$27,05521,000 total
    Exercise: $7.73From: 2014-02-12Exp: 2023-02-12Common Stock (3,500 underlying)
Footnotes (1)
  • [F1]Options to purchase 3,500 shares of the common stock of the Registrant shall become exercisable with respect to the underlying shares as to 25% on each February 12, 2014, 2015, 2016 and 2017, assuming the Reporting Person continues to be employed by the Registrant on the vesting date.

Issuer

OSIRIS THERAPEUTICS, INC.

CIK 0001360886

Entity typeother

Related Parties

1
  • filerCIK 0001476315

Filing Metadata

Form type
4
Filed
Feb 12, 7:00 PM ET
Accepted
Feb 13, 5:36 PM ET
Size
5.4 KB